1. Home
  2. CERS

as of 03-09-2026 10:52am EST

$1.90
$0.04
-1.81%
Stocks Technology EDP Services Nasdaq

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Founded: 1991 Country:
United States
United States
Employees: N/A City: CONCORD
Market Cap: 276.0M IPO Year: 1996
Target Price: N/A AVG Volume (30 days): 1.6M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.08 EPS Growth: 27.27
52 Week Low/High: $1.12 - $2.96 Next Earning Date: 05-22-2026
Revenue: $51,326,000 Revenue Growth: 30.68%
Revenue Growth (this year): 20% Revenue Growth (next year): 9.60%
P/E Ratio: -24.19 Index: N/A
Free Cash Flow: 1.1M FCF Growth: -87.00%

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K SELL

Mar 2, 2026 ยท 100% conf.

AI Prediction SELL

1D

-2.95%

$2.46

Act: -15.81%

5D

-15.80%

$2.13

20D

-12.93%

$2.20

Price: $2.53 Prob +5D: 0% AUC: 1.000
0001193125-26-085350

8-K

false000102021400010202142026-03-022026-03-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 02, 2026

CERUS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Delaware

000-21937

68-0262011

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1220 Concord Avenue, Suite 600

Concord, California

94520

(Address of Principal Executive Offices)

(Zip Code)

Registrantโ€™s Telephone Number, Including Area Code: 925 288-6000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: โ˜Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) โ˜Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) โ˜Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) โ˜Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

CERS

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (ยงโ€ฏ230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (ยงโ€ฏ240.12b-2 of this chapter). Emerging growth company โ˜ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. โ˜

Item 2.02 Results of Operations and Financial Condition. On March 2, 2026, Cerus Corporation (the โ€œCompanyโ€) announced its financial results for its fourth quarter and fiscal year ended December 31, 2025. A copy of the Companyโ€™s press release, entitled โ€œCerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results,โ€ is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

The information in this report, including the exhibit hereto, shall not be deemed to be โ€œfiledโ€ for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

The following exhibit is furnished with this report:

99.1 Press release, dated March 2, 2026, entitled โ€œCerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results.โ€

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CERUS CORPORATION

Date:

March 2, 2026

By:

/s/ Kevin D. Green

Kevin D. Green, Chief Financial Officer

2025
Q4

Q4 2025 Earnings

8-K SELL

Jan 12, 2026 ยท 100% conf.

AI Prediction SELL

1D

-2.95%

$2.46

Act: -15.81%

5D

-15.80%

$2.13

20D

-12.93%

$2.20

Price: $2.53 Prob +5D: 0% AUC: 1.000
0001193125-26-009824

8-K

false000102021400010202142026-01-112026-01-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 11, 2026

CERUS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Delaware

000-21937

68-0262011

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1220 Concord Avenue, Suite 600

Concord, California

94520

(Address of Principal Executive Offices)

(Zip Code)

Registrantโ€™s Telephone Number, Including Area Code: 925 288-6000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: โ˜Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) โ˜Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) โ˜Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) โ˜Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

CERS

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (ยงโ€ฏ230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (ยงโ€ฏ240.12b-2 of this chapter). Emerging growth company โ˜ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. โ˜

Item 2.02 Results of Operations and Financial Condition. On January 11, 2026, Cerus Corporation (the โ€œCompanyโ€) announced its preliminary product revenue results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the Companyโ€™s press release, entitled โ€œCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook,โ€ is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

Such product revenue results as reported are preliminary, unaudited and subject to completion. The Companyโ€™s independent registered public accounting firm has not audited or performed any procedures with respect to these preliminary results and does not express an opinion or any other form of assurance with respect thereto. The Companyโ€™s financial closing procedures for the three months and year ended December 31, 2025 are not yet complete and, as a result, the final results upon completion of the closing procedures may vary from the preliminary estimates, and any such differences may be material. The Companyโ€™s product revenue information presented herein should not be viewed as a substitute for the information set forth in the full financial statements prepared in accordance with U.S. generally accepted accounting principles, and undue reliance should not be placed on these preliminary product revenue results.

The information in this report, including the exhibit hereto, shall not be deemed to be โ€œfiledโ€ for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

The following exhibit is furnished with this report:

99.1 Press release, dated January 11, 2026, entitled โ€œCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook.โ€

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CERUS CORPORATION

Date:

January 11, 2026

By:

/s/ Kevin D. Green

Kevin D. Green Chief Financial Officer

2025
Q3

Q3 2025 Earnings

8-K

Nov 6, 2025

0001193125-25-269451

8-K

false000102021400010202142025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 06, 2025

CERUS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Delaware

000-21937

68-0262011

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1220 Concord Avenue, Suite 600

Concord, California

94520

(Address of Principal Executive Offices)

(Zip Code)

Registrantโ€™s Telephone Number, Including Area Code: 925 288-6000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: โ˜Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) โ˜Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) โ˜Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) โ˜Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

CERS

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (ยงโ€ฏ230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (ยงโ€ฏ240.12b-2 of this chapter). Emerging growth company โ˜ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. โ˜

Item 2.02 Results of Operations and Financial Condition. On November 6, 2025, Cerus Corporation (the โ€œCompanyโ€) announced its financial results for its third quarter ended September 30, 2025. A copy of the Companyโ€™s press release, entitled โ€œCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance,โ€ is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

The information in this report, including the exhibit hereto, shall not be deemed to be โ€œfiledโ€ for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

The following exhibit is furnished with this report:

99.1 Press release, dated November 6, 2025, entitled โ€œCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance.โ€

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CERUS CORPORATION

Date:

November 6, 2025

By:

/s/ Kevin D. Green

Chief Financial Officer

Latest Cerus Corporation News

CERS Breaking Stock News: Dive into CERS Ticker-Specific Updates for Smart Investing

All CERS News

Share on Social Networks: